Ankur Dhingra - 16 Aug 2022 Form 4/A - Amendment Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Chief Financial Officer
Signature
/s/ Ankur Dhingra
Issuer symbol
SMMT
Transactions as of
16 Aug 2022
Net transactions value
+$36,554
Form type
4/A - Amendment
Filing time
08 Mar 2023, 15:58:33 UTC
Date Of Original Report
17 Aug 2022
Previous filing
02 Jun 2022
Next filing
08 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SMMT Common Stock Purchase $12,636 +13,027 +49% $0.9700 39,527 16 Aug 2022 Direct F1
transaction SMMT Common Stock Purchase $23,918 +24,658 +182% $0.9700 38,196 16 Aug 2022 By Dhingra Family Revocable Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is being amended to correct the number of shares purchased by the Reporting Person in the Issuer's rights offering. 1,470 shares were inadvertently omitted from the original filing.
F2 The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.